Therapeutics of Ebola hemorrhagic fever: whole-genome transcriptional analysis of successful disease mitigation.
暂无分享,去创建一个
Sara Garamszegi | John H Connor | Kathleen H Rubins | Judy Y. Yen | Lisa E Hensley | K. Rubins | L. Hensley | J. Connor | T. Geisbert | A. Honko | J. Geisbert | Anna Honko | Thomas W Geisbert | Joan B Geisbert | Judy Y Yen | Yu Xia | Sara Garamszegi | Yu Xia
[1] L. Fernando,et al. Effective Post-Exposure Treatment of Ebola Infection , 2007, PLoS pathogens.
[2] P. Jahrling,et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. , 2003, The American journal of pathology.
[3] P. Rollin,et al. Markedly elevated levels of interferon (IFN)-γ, IFN-α, interleukin (IL)-2, IL-10, and tumor necrosis factor-α associated with fatal Ebola virus infection , 1999 .
[4] Xinxia Peng,et al. Lethal Influenza Virus Infection in Macaques Is Associated with Early Dysregulation of Inflammatory Related Genes , 2009, PLoS pathogens.
[5] J. Dye,et al. Protection of Nonhuman Primates against Two Species of Ebola Virus Infection with a Single Complex Adenovirus Vector , 2010, Clinical and Vaccine Immunology.
[6] C J Peters. Emerging infections--Ebola and other filoviruses. , 1996, The Western journal of medicine.
[7] H. Feldmann,et al. Ebola and Marburg viruses: pathogenesis and development of countermeasures. , 2005, Current molecular medicine.
[8] Ash A. Alizadeh,et al. Stereotyped and specific gene expression programs in human innate immune responses to bacteria , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] Robert Damoiseaux,et al. A broad-spectrum antiviral targeting entry of enveloped viruses , 2010, Proceedings of the National Academy of Sciences.
[10] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[11] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[12] P. Jahrling,et al. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. , 2007, The Journal of infectious diseases.
[13] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[14] R. Ahmed,et al. Monocyte-Derived Human Macrophages and Peripheral Blood Mononuclear Cells Infected with Ebola Virus Secrete MIP-1α and TNF-α and Inhibit Poly-IC-Induced IFN-α in Vitro , 2001 .
[15] Heinz Feldmann,et al. Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus , 2009, Journal of Virology.
[16] Brad T. Sherman,et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.
[17] M. Bray,et al. Ebola hemorrhagic fever and septic shock. , 2003, The Journal of infectious diseases.
[18] Joshua C. Johnson,et al. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study , 2010, The Lancet.
[19] David H. L. Bishop,et al. The International Committee on Taxonomy of Viruses , 1995 .
[20] Gavin Sherlock,et al. Implementation of GenePattern within the Stanford Microarray Database , 2008, Nucleic Acids Res..
[21] Alok J. Saldanha,et al. Java Treeview - extensible visualization of microarray data , 2004, Bioinform..
[22] P. Jahrling,et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys , 2003, The Lancet.
[23] Gordon K. Smyth,et al. A comparison of background correction methods for two-colour microarrays , 2007, Bioinform..
[24] R. Ahmed,et al. Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro. , 2001, Virology.
[25] J. Maniloff,et al. Virus taxonomy : eighth report of the International Committee on Taxonomy of Viruses , 2005 .
[26] Kathleen H Rubins,et al. The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever , 2007, Genome Biology.
[27] H. Feldmann,et al. Progress towards the treatment of Ebola haemorrhagic fever , 2006, Expert opinion on investigational drugs.
[28] M. Kinch,et al. Development of a broad-spectrum antiviral with activity against Ebola virus. , 2009, Antiviral research.
[29] P. Jahrling,et al. Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. , 2003, The Journal of infectious diseases.
[30] Steven J M Jones,et al. Therapy and prophylaxis of Ebola virus infections. , 2005, Current opinion in investigational drugs.
[31] Peters Cj. Emerging infections--Ebola and other filoviruses. , 1996 .
[32] Shinji Watanabe,et al. Replication-Deficient Ebolavirus as a Vaccine Candidate , 2009, Journal of Virology.
[33] Terry Speed,et al. Normalization of cDNA microarray data. , 2003, Methods.
[34] P. Rollin,et al. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. , 1999, The Journal of infectious diseases.
[35] D. Taub,et al. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. , 1995, The Journal of clinical investigation.
[36] F. Marincola,et al. High-fidelity mRNA amplification for gene profiling , 2000, Nature Biotechnology.